Claire Harrison - Articles and news items

Novartis logo

Novartis drug Jakavi® first medication to receive European Commission approval to treat patients with myelofibrosis

Industry news, News / 28 August 2012 / Novartis

Novartis received approval today from the European Commission for Jakavi®…

Novartis logo

Two Phase III studies of Novartis drug INC424 published in NEJM show significant clinical benefit for patients with myelofibrosis

Industry news, News / 29 February 2012 / Novartis

Results of the COMFORT-I and COMFORT-II trials show INC424 significantly reduced disease burden in patients with myelofibrosis…

Novartis logo

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+